COVID-19andtheHeart

Design and rationale of MYOFLAME-19 randomised controlled trial: MYOcardial protection to reduce post-COVID inFLAMmatory heart disease using cardiovascular magnetic resonance Endpoints

Source: Journal of Cardiovascular Magnetic Resonance

Bio-inspired algorithms in machine learning and deep learning for disease detection

Source: Bio-inspired Algorithms in Machine Learning and Deep Learning for Disease Detection

Redox imbalance driven epigenetic reprogramming and cardiovascular dysfunctions: phytocompounds for prospective epidrugs

Source: Phytomedicine

Receipt of respiratory vaccines among patients with heart failure in a multicenter health system registry

Source: Vaccine

Prevalence, causes and outcomes of hospital admissions in Mongolia: a national registry-based descriptive analysis

Source: The Lancet Regional Health - Western Pacific